Dados B3 › MGEL4 × BRKM5
MGEL4 × BRKM5
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | MGEL4 | BRKM5 | year |
|---|---|---|---|
| ROE | 141.3% | -80.9% | 2023 |
| ROIC | 12.3% | -4.3%! | 2025 |
| ROA | 6.6% | -11.9% | 2025 |
| Gross margin | 12.7% | 2.2% | 2025 |
| EBIT margin | 7.0% | -2.6% | 2025 |
| Net margin | 4.5% | -15.5% | 2025 |
| Net debt/EBITDA | 5.18x | 13.95x | 2025 |
| Current ratio | 0.46x | 0.76x | 2025 |
| Revenue growth (1y) | 12.2% | -8.6% | 2025 |
| Revenue growth (5y CAGR) | 14.2% | 3.9% | 2025 |
| Piotroski F-Score | 8/9 | 3/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | MGEL4 | BRKM5 | year |
|---|---|---|---|
| P/E | 0.76x | -0.73x | 2025 |
| P/B | 0.78x | — | 2025 |
| EV/EBITDA | 5.57x | 16.47x | 2025 |
| FCF yield | 234.3% | -101.1% | 2025 |
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-09 14:22 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.